3 Minute Read
Regulatory Market Update Updates for Pharma Manufacturers As always, if you have questions on any of the content found in this or previous market updates, please reach out to...
5 Minute Read
And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.
4 Minute Read
Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.
3 Minute Read
As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?
4 Minute Read
This month we discuss COVID-19 vaccine mandates, the recent HHS drug discount ruling, and Medicare drug price reforms.
4 Minute Read
We discuss the Biden administration's plan for combatting high drug prices, the new PBM public law reporting cycle, and MA and Part D rule for 2022.
3 Minute Read
We review how discount cards have disrupted the prescription market as well as updates to the most-favored-nation pricing model and new STPR laws in Maine.
5 Minute Read
Six key elements to operate an effective compliance program. Also, new VA FSS rules for vaccine drugs, State Price Transparency, and Medicare Part D updates and reminders.
4 Minute Read
We'll tell you how to prepare. Plus new manufacturer awareness for orphan drugs, midnight changes to MDRP, and upholding the ACA.